Form 8-K

8-K — National Healthcare Properties, Inc.

Accession: 0001561032-26-000043

Filed: 2026-06-16

Period: 2026-06-15

CIK: 0001561032

SIC: 6798 (REAL ESTATE INVESTMENT TRUSTS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — hct-20260615.htm (Primary)

EX-99.1 (ex991.htm)

GRAPHIC (image_0.jpg)

GRAPHIC (image_1.jpg)

GRAPHIC (image_2.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: hct-20260615.htm · Sequence: 1

hct-20260615

FALSE000156103200015610322026-06-152026-06-150001561032us-gaap:CommonClassAMember2026-06-152026-06-150001561032hct:SeriesACumulativeRedeemablePerpetualPreferredStockMember2026-06-152026-06-150001561032hct:SeriesBCumulativeRedeemablePerpetualPreferredStockMember2026-06-152026-06-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 15, 2026

National Healthcare Properties, Inc.

(Exact Name of Registrant as Specified in Charter)

Maryland 001-39153 38-3888962

(State or other jurisdiction

of incorporation) (Commission File Number) (I.R.S. Employer

Identification No.)

540 Madison Ave., 27th Floor

New York, NY 10022

__________________________________________________________________________________________________________________________________________________________________________

(Address, including zip code, of Principal Executive Offices)

Registrant’s telephone number, including area code: (332) 258-8770

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Class A common stock, $0.01 par value per share NHP The Nasdaq Global Market

7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share NHPAP The Nasdaq Global Market

7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share NHPBP The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events.

National Healthcare Properties, Inc. (the “Company”) has been notified that on June 15, 2026, MacKenzie Capital Management, LP and its affiliates (collectively, “MacKenzie”) launched an unsolicited “mini-tender” offer to purchase up to 150,000 shares of the Company’s common stock, $0.01 par value per share (“common stock”), which in aggregate represents approximately 0.2% of the Company’s outstanding shares of common stock (including the Company’s Class A common stock, $0.01 par value per share), at a price of $7.27 per share (the “MacKenzie Offer”), subject to certain terms and conditions set forth in MacKenzie’s Offer to Purchase Shares. The Company is not affiliated with MacKenzie or the MacKenzie Offer.

After careful evaluation of the MacKenzie Offer, the Company determined (i) not to make any recommendation and (ii) to remain neutral as to whether stockholders should tender their shares of the Company’s common stock in the MacKenzie Offer.

On June 16, 2026, the Company published a letter to its stockholders on its website notifying them of the decision of the Company to not make any recommendation and to remain neutral regarding the MacKenzie Offer. A copy of the letter is furnished as Exhibit 99.1 hereto and incorporated by reference herein.

The material terms of the Underwriting Agreement are qualified in their entirety by the agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1

Letter to Stockholders regarding the MacKenzie Offer.

104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NATIONAL HEALTHCARE PROPERTIES, INC.

Date: June 16, 2026

By:

/s/ Andrew T. Babin

Andrew T. Babin

Chief Financial Officer and Treasurer

EX-99.1

Filename: ex991.htm · Sequence: 2

Document

NHP MAKES NO RECOMMENDATION WITH RESPECT TO THE MACKENZIE TENDER OFFER

June 16, 2026

Dear Stockholder:

Thank you for your investment in National Healthcare Properties, Inc. (“NHP”). On behalf of NHP and its Board of Directors, we are writing to notify you that on June 15, 2026, MacKenzie Capital Management, LP and its affiliates (collectively, “MacKenzie”) launched an unsolicited mini-tender offer (the “MacKenzie Offer”) to purchase up to 150,000 shares of NHP common stock, $0.01 par value per share (“common stock”), at a price of $7.27 per share (the “MacKenzie Offer Price”). NHP IS NEITHER AFFILIATED WITH MACKENZIE NOR THE MACKENZIE OFFER.

NHP is required by the Securities Exchange Act of 1934, as amended, to inform you of its position, if any, regarding the MacKenzie Offer. After carefully evaluating the Mackenzie Offer and consulting with outside advisors, WE HAVE DETERMINED (I) NOT TO MAKE ANY RECOMMENDATION AND (II) TO REMAIN NEUTRAL AS TO WHETHER STOCKHOLDERS SHOULD TENDER THEIR SHARES IN THE MACKENZIE OFFER. In arriving at this decision, we considered, among other things, the following factors:

•Mackenzie’s Offer Price of $7.27 per share is approximately 47.2% lower than $13.78 per share, which is the last reported sale price of NHP’s Class A common stock, $0.01 par value per share (“Class A common stock”), on The Nasdaq Global Market (“Nasdaq”) as of June 15, 2026. On April 23, 2026, pursuant to a Registration Statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on Form S-11, as amended, NHP completed a public offering (the “Offering”) and issued an aggregate of 44,275,000 shares of Class A common stock. In connection with the Offering, NHP’s Class A common stock became listed on Nasdaq under the symbol “NHP” and began trading on April 22, 2026. Each share of Class A common stock will automatically convert into one share of NHP’s existing common stock on October 19, 2026 (the “Class A Conversion”), and all shares of common stock will subsequently be listed and freely tradeable on Nasdaq under the symbol “NHP.”

•As disclosed in connection with the Offering process, NHP anticipates making quarterly cash distributions to holders of common stock (including Class A common stock) subject to the approval of NHP’s Board of Directors. There is no guarantee of future distributions and there can be no certainty regarding the long-term value of NHP’s common stock because the value is dependent on a number of factors. In addition, NHP’s charter allows it to issue additional preferred stock that could have a preference on distributions and could limit NHP’s ability to make distributions to holders of common stock (including Class A common stock), and NHP’s agreements relating to indebtedness could limit its ability to make distributions to stockholders under certain circumstances. However, stockholders who tender their shares pursuant to the MacKenzie Offer would give up their rights to any future distributions after March 31, 2026.

•Pursuant to the MacKenzie Offer, the MacKenzie Offer Price will be reduced by any cash distributions made to stockholders by NHP after March 31, 2026. Any such distribution will be assigned to MacKenzie as a condition to the MacKenzie Offer.

•We believe that the MacKenzie Offer represents an opportunistic attempt by MacKenzie to purchase shares of common stock and make a profit. We are aware that there is currently no active share repurchase plan or other method of liquidation for the common stock (except for Class A common stock) until the Class A Conversion and that stockholders may want near-term liquidity. NHP stockholders seeking immediate liquidity may have other options, including secondary auction trades, which MacKenzie points out may result in a higher sales price, with MacKenzie noting that for the period between April to May 2026, “…the Shares reported by CTT Auctions were $8.41-$11.41 per Share [with respect to common stock]”, which represent actual sales of NHP common stock at prices that are approximately 13.6%-36.3% higher than the MacKenzie Offer Price.

•As stated by MacKenzie, the MacKenzie Offer is being made “in view of making a profit, so the price offered is below the estimate of value as established by [MacKenzie].” MacKenzie determined the MacKenzie Offer Price pursuant to its own analysis and states that they are “not real estate appraisers” and that “the value of the assets may not accurately represent the current or future value of the [common stock].” Furthermore, MacKenzie did not retain an independent advisor to evaluate or render an opinion as to the fairness of the MacKenzie Offer Price. Hence, MacKenzie acknowledges that its offer price was established based on MacKenzie’s own analysis and objectives without consideration of your financial objectives.

•None of NHP’s directors, executive officers, affiliates or subsidiaries intend to tender their shares of common stock to MacKenzie.

We urge you to consult your financial advisor and exercise caution with respect to this and other mini-tender offers. The SEC has cautioned investors about these kinds of offers in an investor alert, as they are often made in an attempt to profit at investors’ expense. The SEC noted that these offers “have been increasingly used to catch investors off guard,” and cautioned that investors need to scrutinize these types of offers carefully. To read more about the risks of “mini-tender” offers, please review the alert at www.sec.gov/investor/pubs/minitend.htm.

SEC rules permit third parties, such as MacKenzie, to distribute unsolicited mini-tender offers to stockholders of public companies. However, in order to maintain the confidentiality of our stockholders, NHP has only provided stockholder mailing information needed to distribute the MacKenzie Offer materials to a third-party financial printer that is unaffiliated with MacKenzie. Therefore, MacKenzie will not have access to any additional stockholder information unless the stockholder agrees to accept the MacKenzie Offer.

We recognize that stockholders may decide to accept the MacKenzie Offer for several reasons: their individual liquidity needs and financial situation; the MacKenzie Offer providing a set cash price compared to the current trading price of Class A common stock, which may fluctuate due to market conditions; the non-existence of a NHP stock repurchase plan with respect to common stock; and the lack of a current trading market for common stock until October 19, 2026.

We strongly urge you to carefully consider all aspects of the MacKenzie Offer in light of your own circumstances, including (i) your investment objectives, (ii) your financial circumstances, including your tolerance for risk and need for immediate liquidity that cannot be satisfied by other means, (iii) other financial opportunities available to you, (iv) your own tax position and tax consequences, and (v) other factors you determine are relevant to your decision. You should carefully review all of the MacKenzie Offer documents sent to you by MacKenzie, as well as NHP’s publicly available annual, quarterly and other reports filed with the SEC at www.sec.gov, and consult with your own financial, tax and other advisors in evaluating the MacKenzie Offer before deciding whether to tender your shares of common stock. We appreciate that stockholders must evaluate whether to tender their shares based on all the information available, including the factors considered by NHP above.

PLEASE CONSULT WITH YOUR FINANCIAL ADVISOR AND TAX ADVISOR ABOUT THE IMPACT OF A SALE ON YOUR OWN PARTICULAR SITUATION.

As always, thank you for your investment, confidence in us and continued support. Should you have any questions or need further information about your options, please feel free to contact your financial advisor or NHP Investor Relations at ir@nhpreit.com.

Sincerely,

Michael Anderson

Chief Executive Officer and President

Andrew Babin

Chief Financial Officer and Treasurer

Cautionary Note Regarding Forward-Looking Statements

This letter may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by the use of terminology such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “should,” “predict,” “project,” “potential,” “continue” or the negatives of these terms or variations of them or similar expressions. Risks and uncertainties, the occurrence of which could adversely affect NHP’s business and cause actual results to differ materially from those expressed or implied in the forward-looking statements, include, but are not limited to, the following: the trading price of Class A common stock; the Class A Conversion; changes in economic cycles generally and in the real estate and healthcare markets specifically; the success of NHP’s growth strategy, including its ability to successfully identify, complete and integrate new acquisitions; NHP’s ability to complete acquisitions or dispositions on the terms and timing NHP expects, or at all; changes to inflation and interest rates; competition in the real estate and healthcare markets; NHP’s ability to retain certain key personnel; legislative and regulatory changes in the healthcare and real estate industries; reductions or changes in reimbursement from third-party payors, including Medicare and Medicaid; discovery of previously undetected environmentally hazardous conditions; NHP’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; system failures, cyber incidents or deficiencies in NHP’s cybersecurity systems; the availability of capital on favorable terms, or at all; NHP’s ability to remain qualified as a real estate investment trust for U.S. federal income tax purposes; and other risks and uncertainties described in the section titled Risk Factors of NHP’s most recent Annual Report on Form 10-K and all other lings with the Securities and Exchange Commission. Finally, NHP assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

GRAPHIC

Filename: image_0.jpg · Sequence: 7

Binary file (38077 bytes)

Download image_0.jpg

GRAPHIC

Filename: image_1.jpg · Sequence: 8

Binary file (16690 bytes)

Download image_1.jpg

GRAPHIC

Filename: image_2.jpg · Sequence: 9

Binary file (45343 bytes)

Download image_2.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 11

v3.26.1

Cover Page

Jun. 15, 2026

Document Information [Line Items]

Document Type

8-K

Document Period End Date

Jun. 15, 2026

Entity Registrant Name

National Healthcare Properties, Inc.

Entity Incorporation, State or Country Code

Entity File Number

001-39153

Entity Tax Identification Number

38-3888962

Entity Address, Address Line One

540 Madison Ave.

Entity Address, Address Line Two

27th Floor

Entity Address, City or Town

New York

Entity Address, State or Province

Entity Address, Postal Zip Code

10022

City Area Code

332

Local Phone Number

258-8770

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Amendment Flag

false

Entity Central Index Key

0001561032

Series A Cumulative Redeemable Perpetual Preferred Stock

Document Information [Line Items]

Title of 12(b) Security

7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share

Trading Symbol

NHPAP

Security Exchange Name

NASDAQ

Series B Cumulative Redeemable Perpetual Preferred Stock

Document Information [Line Items]

Title of 12(b) Security

7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share

Trading Symbol

NHPBP

Security Exchange Name

NASDAQ

Common Class A

Document Information [Line Items]

Title of 12(b) Security

Class A common stock, $0.01 par value per share

Trading Symbol

NHP

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=hct_SeriesACumulativeRedeemablePerpetualPreferredStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=hct_SeriesBCumulativeRedeemablePerpetualPreferredStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: